Introduction Identifying ankylosing spondylitis (AS) patients who are likely to benefit from
tumor necrosis factor-alpha (TNF-α) blocking therapy is important, especially in view of the …

Osteoporosis is a well recognized complication of ankylosing spondylitis (AS). This study
indicates that increased bone turnover, inflammation, and low vitamin D levels are important in …

Background Progression of joint destruction in rheumatoid arthritis (RA) is partly heritable;
knowledge of genetic factors may increase our understanding of the mechanisms underlying …

Objective. To report 8 patients with Sjögren’s syndrome (SS) and localized nodular cutaneous
amyloidosis and to examine serologic and immunohistologic findings that may link the 2 …

Introduction The aim of this study was to investigate the effect of three years of tumor necrosis
factor-alpha (TNF-α) blocking therapy on bone turnover as well as to analyze the predictive …

Objective. To investigate whether level of serum matrix metalloproteinase-3 (MMP-3) can serve
as a biomarker for monitoring and predicting response to etanercept treatment in patients …

Introduction Ankylosing spondylitis (AS) is characterized by excessive bone formation and
bone loss. Our aim was to investigate the association of bone turnover markers (BTM) with …

Objective: To study the clinical and pathological characteristics of two patients with laryngeal
apolipoprotein A‐I (apoA‐I)‐derived (AApoAI) amyloidosis with the apolipoprotein A‐I …

Introduction Progression of joint destruction in rheumatoid arthritis (RA) is partly heritably;
45 to 58% of the variance in joint destruction is estimated to be explained by genetic factors. …

We present the case of an 11-year-old boy presenting with haemoptysis, dyspnoea and
weight loss as a manifestation of isolated pulmonary vasculitis, leading to pulmonary …